Aurora Cannabis Inc Market Cap ($259.21 Million)
Market Cap & Net Worth: Aurora Cannabis Inc (ACB)
Aurora Cannabis Inc market cap. Aurora Cannabis Inc (TO:ACB) has a market capitalization of $259.21 Million (CA$358.33 Million) as of November 1, 2026. Listed on the TO stock exchange, this Canada-based company holds position #15257 globally and #453 in its home market, demonstrating a 1.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aurora Cannabis Inc's stock price CA$5.66 by its total outstanding shares 63310061 (63.31 Million). Also see Aurora Cannabis Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Aurora Cannabis Inc Market Cap History (2015–2026)
Aurora Cannabis Inc market cap history from 2015 to 2026. Data shows growth from $27.17 Million to $259.21 Million (26.70% CAGR). Check Aurora Cannabis Inc (ACB) stock price for real-time trading data and today's change.
Aurora Cannabis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aurora Cannabis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Aurora Cannabis Inc (ACB) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.81x
Aurora Cannabis Inc's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $52.76 Billion | $18.07 Million | -$12.97 Million | 2920.17x | N/A |
| 2018 | $37.26 Billion | $55.20 Million | $71.94 Million | 675.06x | 517.97x |
| 2019 | $15.33 Billion | $245.54 Million | -$293.51 Million | 62.45x | N/A |
| 2020 | $4.85 Billion | $268.70 Million | -$3.28 Billion | 18.07x | N/A |
| 2021 | $3.14 Billion | $245.25 Million | -$693.62 Million | 12.79x | N/A |
| 2022 | $572.47 Million | $221.34 Million | -$1.72 Billion | 2.59x | N/A |
| 2023 | $297.68 Million | $233.29 Million | -$265.33 Million | 1.28x | N/A |
| 2024 | $279.82 Million | $270.28 Million | -$69.33 Million | 1.04x | N/A |
| 2025 | $264.25 Million | $343.29 Million | $1.59 Million | 0.77x | 166.09x |
| 2026 | $259.21 Million | $320.59 Million | -$121.76 Million | 0.81x | N/A |
Competitor Companies of ACB by Market Capitalization
Companies near Aurora Cannabis Inc in the global market cap rankings as of November 1, 2026. Also see Aurora Cannabis Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Aurora Cannabis Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Aurora Cannabis Inc (2015–2026)
Market capitalization of Aurora Cannabis Inc from 2015 to today. Between 2015 and today, Aurora Cannabis Inc's market cap moved from $27.17 Million to $ 259.21 Million, with a yearly change of 26.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$259.21 Million | -1.91% |
| 2025 | CA$264.25 Million | -5.56% |
| 2024 | CA$279.82 Million | -6.00% |
| 2023 | CA$297.68 Million | -48.00% |
| 2022 | CA$572.47 Million | -81.75% |
| 2021 | CA$3.14 Billion | -35.38% |
| 2020 | CA$4.85 Billion | -68.34% |
| 2019 | CA$15.33 Billion | -58.85% |
| 2018 | CA$37.26 Billion | -29.38% |
| 2017 | CA$52.76 Billion | +317.39% |
| 2016 | CA$12.64 Billion | +46419.47% |
| 2015 | CA$27.17 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Aurora Cannabis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $259.21 Million USD |
| MoneyControl | $259.21 Million USD |
| MarketWatch | $259.21 Million USD |
| marketcap.company | $259.21 Million USD |
| Reuters | $259.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more